Troponin I1, skeletal, slow (TNNI1) (TNNI1)

Troponin I1, skeletal, slow (TNNI1) is the inhibitory subunit of the troponin complex specifically expressed in slow-twitch (Type I) skeletal muscle fibers (UniProt P19237). It functions by binding to actin and inhibiting the actomyosin ATPase activity in the absence of calcium, thereby preventing muscle contraction (NCBI Gene ID: 7135). Upon calcium binding to troponin C, TNNI1 dissociates from actin, allowing the contraction cycle to proceed. Genetic variants in TNNI1 are linked to neuromuscular disorders such as distal arthrogryposis type 2B and other congenital myopathies (PMID: 24038944). In clinical diagnostics, TNNI1 serves as a highly specific serum biomarker for slow-twitch muscle fiber injury, distinct from cardiac or fast-twitch isoforms (PMID: 30135102). While therapeutic development has primarily targeted fast-twitch troponin (TNNI2) for conditions like ALS, TNNI1 remains a target of interest for addressing slow-fiber-specific weakness and as a diagnostic tool for muscle health. Drugs that modulate the troponin complex, such as skeletal muscle troponin activators, aim to increase the sensitivity of the myofibril to calcium, thereby enhancing muscle force (PMID: 27108165). This mechanism is particularly relevant in diseases characterized by impaired neuromuscular signaling or muscle atrophy.

Other names

Troponin I, slow skeletal muscle isoformsTnITNN1Troponin I, skeletal, slow-twitch

Troponin activation and calcium sensitization of the skeletal muscle myofibril